1. Home
  2. ASTE vs EYPT Comparison

ASTE vs EYPT Comparison

Compare ASTE & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ASTE

Astec Industries Inc.

HOLD

Current Price

$51.00

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$11.92

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTE
EYPT
Founded
1972
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2003
2005

Fundamental Metrics

Financial Performance
Metric
ASTE
EYPT
Price
$51.00
$11.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$66.00
$31.80
AVG Volume (30 Days)
142.2K
1.5M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
0.85%
N/A
EPS Growth
784.21
N/A
EPS
0.06
N/A
Revenue
N/A
$7,539,000.00
Revenue This Year
$14.72
N/A
Revenue Next Year
$5.44
$3,115.57
P/E Ratio
$914.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$37.88
$9.41
52 Week High
$65.69
$19.11

Technical Indicators

Market Signals
Indicator
ASTE
EYPT
Relative Strength Index (RSI) 38.51 36.19
Support Level $49.93 $9.65
Resistance Level $54.17 $13.32
Average True Range (ATR) 1.94 0.81
MACD -0.39 -0.23
Stochastic Oscillator 1.45 3.24

Price Performance

Historical Comparison
ASTE
EYPT

About ASTE Astec Industries Inc.

Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. The company has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

Share on Social Networks: